Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
205,784,378
-
Share change
-
+4,917,847
-
Total reported value
-
$2,961,545,572
-
Put/Call ratio
-
92%
-
Price per share
-
$14.39
-
Number of holders
-
179
-
Value change
-
+$69,146,736
-
Number of buys
-
97
-
Number of sells
-
80
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2017
As of 31 Dec 2017,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
179 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
205,784,378 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Vanguard Group Inc, Redmile Group, LLC, JENNISON ASSOCIATES LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and venBio Select Advisor LLC.
This page lists
179
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.